MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Kythera Biopharmaceuticals Company Profile (NASDAQ:KYTH)

Consensus Ratings for Kythera Biopharmaceuticals (NASDAQ:KYTH) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $61.25 (17.98% downside)

Analysts' Ratings History for Kythera Biopharmaceuticals (NASDAQ:KYTH)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2015Leerink SwannDowngradeOutperform -> Market Perform$61.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2015GuggenheimInitiated CoverageBuy$64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2015Bank of AmericaInitiated CoverageBuy$66.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015Leerink SwannBoost Price TargetOutperform$50.00 -> $61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2014FBR & Co.Lower Price TargetOutperform$62.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2013FBR & Co.Initiated CoverageOutperform$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/25/2013Bank of AmericaInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013JPMorgan Chase & Co.Boost Price TargetOverweight$34.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013Cowen and CompanyReiterated RatingBuy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013Leerink SwannBoost Price Target$34.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013Goldman SachsInitiated CoverageNeutral$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/6/2013Cowen and CompanyInitiated CoverageOutperform$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha